As coronavirus continues to evolve here in the US and globally, we have been taking proactive measures to safeguard the health of our employees. We are monitoring our employee health daily and are in regular communication with our suppliers, customers and governments to ensure we prioritize our activities.

A breakthrough in breast cancer diagnostic imaging

Seno Medical’s imaging system uses opto-acoustic technology interleaved with ultrasound (OA/US) to generate functional and anatomical images of the breast. As a new imaging modality, Seno believes that its Imagio® breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancies than current diagnostic imaging approaches, without exposing patients to potentially harmful ionizing radiation (X-rays) or contrast agents, including breast cancer biopsies.

Clinical Trials

Studies are an essential component
of our opto-acoustic
technology research.

The Seno Advantage

Understand advantages of
opto-acoustic imaging over current
diagnostic imaging techniques.

Product Applications

Discover how Seno Medical’s
opto-acoustic technology will be
applied beyond breast imaging.

How Seno’s Technology Works
Seno’s opto-acoustic technology combines both laser optics and conventional ultrasound technology to provide fused functional and anatomical breast imaging in real time. The result is a diagnostic imaging tool that delivers additional functional information regarding suspicious breast masses and potentially increases confidence regarding the need for breast cancer diagnostic biopsies.

Reducing unnecessary breast cancer biopsies:
Why it matters

Hope for a more accurate breast
cancer diagnosis?
A clinical trial investigating a non-invasive, radiation-free imaging system that has the potential to help doctors more effectively determine which patients need breast biopsies has been completed.